Last reviewed · How we verify

NCT04992585

Primary Versus Secondary Metal Stent Implantation in PTBD

Completed NA Last updated 12 August 2021
What this trial tests

NA trial testing Percutaneous transhepatic implantation of self-expandable metal stent in Bile Duct Obstruction in 40 participants. Completed in 1 March 2021.

Timeline
1 March 2011
Primary endpoint
1 March 2021
1 March 2021

Quick facts

Lead sponsorTheresienkrankenhaus und St. Hedwig-Klinik GmbH
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment40
Start date1 March 2011
Primary completion1 March 2021
Estimated completion1 March 2021
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

Theresienkrankenhaus und St. Hedwig-Klinik GmbH — full company profile →

Who can join

Adults 18 to 100, any sex, with Bile Duct Obstruction or Extrahepatic Cholestasis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim is to compare percutaneous transhepatic biliary drainage (PTBD) with primary metal stent implantation (one stage-procedure) with PTBD with secondary metal stent implantation in terms of adverse events.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Theresienkrankenhaus und St. Hedwig-Klinik GmbH trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04992585.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing